Today's story
FDA approves AbbVie’s Juvmo for Parkinson’s
The FDA approved AbbVie’s once-daily oral drug Juvmo (tavapadon) for adults with Parkinson’s disease. Phase 3 trials found improvements in motor symptoms and daily function, adding another treatment option; common side effects included nausea, headache and dizziness.
Health · 9 sources · 18hRead it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About AbbVie
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Everything about AbbVie →- Country
- United States
- Headquarters
- North Chicago
- Inception
- April 10, 2012
- Website
- http://www.abbvie.com